Navigation Links
Gene expression test distinguishes btw breast cancer patients at high & low risk of late recurrence
Date:5/2/2013

, of patients who were classified by the test as having low risk, 98.7% had not had a late metastasis between 5 and 10 years of follow-up, compared to 91.5% of those with a high PAM50 ROR score. This was true both for node-positive and node-negative disease.

"It makes a huge difference whether a patient looks at an individual risk of 1.3% or 8.5% between years 5 and 10. This is more than six times as much risk. Such important information may well be implemented into individual treatment decisions," Prof Gnant says.

The researchers conclude that the PAM50 ROR score can successfully be used to differentiate patients with respect to their risk for late metastasis, in addition to established clinical and pathological risk factors.

This ability to predict late metastasis may be used in the future to identify patients with endocrine-responsive breast cancer who need or alternatively who can be spared extended adjuvant therapy, they say.

"We have to admit that at this point we cannot prove definitely that we will improve the outcome in patients we have now identified as high risk by extending their adjuvant therapy, but it appears logical that this may be the case. At least as important, if we can define an individual patient reliably as low risk, we can spare her the burden of unnecessary treatment extension," Prof Gnant says.

Commenting on the results, Dr W Fraser Symmans, Professor and Director of Research Operations, Department of Pathology at the University of Texas M.D. Anderson Cancer Center, USA, said they were important for prognostic testing of early breast cancers and for confidently limiting the duration of endocrine therapy to 5 years for women with low-risk disease.

"In the last 6 months it has become clear that three prognostic tests, including the PAM50 ROR score, have similar prognostic utility that holds for up to 15 years after initial diagnosis. It is particularly exciting for the diagnostic commu
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. IU biologists offer clearer picture of how protein machine systems tweak gene expression
2. A new application allows online statistical analysis of gene-expression data
3. Measuring progesterone receptor expression to improve hormone-receptor-positive cancer management
4. Fish show autism-like gene expression in water with psychoactive pharmaceuticals
5. Controlling gene expression with hydrogen peroxide switches
6. Molecular economics: New computer models calculate systems-wide costs of gene expression
7. Controlling gene expression: How chromatin remodelers block a histone pass
8. Study finds how BPA affects gene expression, anxiety; Soy mitigates effects
9. Nutrient in eggs and meat may influence gene expression from infancy to adulthood
10. Whitehead scientists identify major flaw in standard approach to global gene expression analysis
11. Oxidative stress and altered gene expression occurs in a metabolic liver disease model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... Carolina , 5. Februar 2015 /PRNewswire/ ... als spezialisiertes Logistikunternehmen und hat eine neue ... klinische Logistikfirma (Clinical Logistics Organization – CLO) ... neuen Kampagne lautet First , mit ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... ( http://www.nxt-id.com/ ) as part of its 2015 marketing ... Company launched its new consumer website for Wocketwallet.com earlier ... CEO of NXT-ID said, "Our new corporate website naturally ...
(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... was lost in the shadows of cancer research for decades ... Mina Bissell, Distinguished Scientist with Berkeley Lab,s Life Sciences Division ... aerobic glycolysis - glucose metabolism in the presence of oxygen ... malignant cells but is itself a cancerous event. "A ...
... and said about "platinum" open access as a step beyond ... has been seen of its practical implementation. On 1 January ... Deutsche Entomologische Zeitschrift and Zoosystematics and Evolution ... joining the journal publishing platform of Pensoft Publishers and adopting ...
... Halomonas are a hardy breed of bacteria. ... and pressures that would kill most other organisms. These traits ... sandstone formations that also happen to be useful for hydrocarbon ... The analysis , the first unobstructed view of ...
Cached Biology News:Role for sugar uptake in breast cancer revealed 2Role for sugar uptake in breast cancer revealed 32 of the oldest German journals in Zoology go for 'platinum' open access 2Oil- and metal-munching microbes dominate deep sandstone formations 2
(Date:2/26/2015)... NY (PRWEB) February 26, 2015 According ... Research “Agricultural Biotechnology Market For Transgenic Crops (Corn, Soybean, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... at USD 15,300 million in 2012 and is expected ... a CAGR of 9.5% from 2013 to 2019. ...
(Date:2/26/2015)... , Feb. 26, 2015 Tauriga Sciences, ... sciences company with interests in the natural wellness sector ... announced today that its products will be featured at ... Capital Partners, 27 th Annual Growth Stock Conference ... located at 1 Ritz Carlton Drive, Dana ...
(Date:2/26/2015)... 26, 2015 CytomX, a biotechnology company developing ... that Sean McCarthy , D. Phil., chief executive ... Cowen and Company 35 th Annual Health Care ... presentation will take place at 4 p.m. EST on ... CytomX Therapeutics develops Probody™ therapeutics for the treatment of ...
(Date:2/25/2015)... 25, 2015 /CNW/ - Radient Technologies Inc. (TSX-V: RTI) (the ... results for the third quarter of its fiscal year ... Discussion and Analysis, and the CEO & CFO certifications ... 31, 2014 are available on www.SEDAR.com ... The Corporation is also pleased to announce the appointment ...
Breaking Biology Technology:Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 4Radient Technologies Inc. Releases Third Quarter Results and Appoints New Interim CFO 2
... Germany and MILAN, October 18, 2011 ... at EuroSpine Milan for the first time, opening up ... For the first time joimax® presents the ... the novel pain therapy product "Multiuse". The new Multiuse-Set ...
... TARRYTOWN, N.Y., Oct. 17, 2011 Regeneron Pharmaceuticals, Inc. ... it intends to offer, subject to market and other ... notes due 2016 in a private placement.  The notes ... qualified institutional buyers pursuant to Rule 144A under the ...
... Cellular Dynamics International (CDI) today announced that it ... Wall Street Journal Technology Innovation Awards. ... are determined by a panel of independent judges who evaluated ... the award in 16 categories.  Of these, the panel chose ...
Cached Biology Technology:joimax® Launches Numerous Innovations at EuroSpine Milan From 19 To 21 October 2011 2Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016 2Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016 3Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016 4Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016 5Cellular Dynamics International's (CDI) Human Induced Pluripotent Stem Cell (iPSC) Technology Named the Gold Winner in The Wall Street Journal 2011 Technology Innovation Awards 2
Request Info...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
...
Rabbit polyclonal to Quinolinic acid ( Abpromise for all tested applications). Antigen: Synthetic quinolinic acid conjugated to bovine serum albumin....
Biology Products: